{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:41:49Z","timestamp":1769107309559,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.pupt.2021.102071","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T02:00:55Z","timestamp":1629511255000},"page":"102071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension"],"prefix":"10.1016","volume":"70","author":[{"given":"Rosario","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-7963","authenticated-orcid":false,"given":"Marisa","family":"Talarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6549-5102","authenticated-orcid":false,"given":"Filippo","family":"Schepis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Coppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Alfredo","family":"Sgura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Enrique","family":"Monopoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-0851","authenticated-orcid":false,"given":"Roberto","family":"Minici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pupt.2021.102071_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/apt.12140","article-title":"Review article: liver transplantation for the pulmonary disorders of portal hypertension","volume":"37","author":"Houlihan","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12328-019-00956-0","article-title":"Vascular syndromes in liver cirrhosis","volume":"12","author":"Shenoda","year":"2019","journal-title":"Clin. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0037-1606251","article-title":"Portopulmonary hypertension","volume":"38","author":"Savale","year":"2017","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.pupt.2021.102071_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.pupt.2021.102071_bib5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.pupt.2021.102071_bib6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.pupt.2021.102071_bib7","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.52.9.1355","article-title":"Portopulmonary hypertension in decompensated cirrhosis with refractory ascites","volume":"52","author":"Benjaminov","year":"2003","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.pupt.2021.102071_bib8","first-page":"1440","volume":"100","author":"Krowka","year":"2016","journal-title":"\u201cInternational Liver Transplant Society Practice Guidelines,\u201d Transplantation"},{"issue":"7","key":"10.1016\/j.pupt.2021.102071_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.pupt.2021.102071_bib10","doi-asserted-by":"crossref","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2021.102071_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.pupt.2021.102071_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.pupt.2021.102071_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jacc.2018.12.076","article-title":"Anatomy, function, and dysfunction of the right ventricle","volume":"73","author":"Sanz","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.pupt.2021.102071_bib14","doi-asserted-by":"crossref","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjcard.2017.05.053","article-title":"Load adaptability in patients with pulmonary arterial hypertension","volume":"120","author":"Amsallem","year":"2017","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.pupt.2021.102071_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jcmg.2011.11.020","article-title":"RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness","volume":"5","author":"Stevens","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.pupt.2021.102071_bib17","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1164\/rccm.201806-1160ST","article-title":"Assessment of right ventricular function in the research setting: knowledge gaps and pathways forward. An Official American Thoracic Society Research Statement","volume":"198","author":"Lahm","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCIMAGING.113.000640","article-title":"Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension","volume":"6","author":"Fine","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/CIRCHEARTFAILURE.112.000008","article-title":"Right ventricular dysfunction in systemic sclerosis\u2013associated pulmonary arterial hypertension","volume":"6","author":"Tedford","year":"2013","journal-title":"Circ. Hear. Fail."},{"issue":"2","key":"10.1016\/j.pupt.2021.102071_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200912-1820OC","article-title":"Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension","volume":"182","author":"Campo","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.pupt.2021.102071_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S2213-2600(19)30143-2","article-title":"Cardiopulmonary haemodynamics in portopulmonary hypertension","volume":"7","author":"Ghofrani","year":"2019","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.pupt.2021.102071_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010568","article-title":"Prognostic value of cardiac magnetic resonance\u2013derived right ventricular remodeling parameters in pulmonary hypertension","volume":"13","author":"Dong","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"4","key":"10.1016\/j.pupt.2021.102071_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ccm.2017.08.002","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension","volume":"38","author":"Iqbal","year":"2017","journal-title":"Clin. Chest Med."},{"issue":"4","key":"10.1016\/j.pupt.2021.102071_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CRD.0000000000000195","article-title":"Diagnosis, treatment, and management of orthotopic liver transplant candidates with portopulmonary hypertension","volume":"26","author":"Koulava","year":"2018","journal-title":"Cardiol. Rev."},{"issue":"11","key":"10.1016\/j.pupt.2021.102071_bib25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00210-015-1160-z","article-title":"Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice","volume":"388","author":"Serafim","year":"2015","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.pupt.2021.102071_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/jpet.114.220491","article-title":"Multiple compound-related adverse properties contribute to liver injury caused by endothelin receptor antagonists","volume":"352","author":"Kenna","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40264-015-0275-y","article-title":"Comparative safety and tolerability of endothelin receptor antagonists in pulmonary arterial hypertension","volume":"38","author":"Aversa","year":"2015","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.pupt.2021.102071_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfx062","article-title":"From the cover: MechanisticInsights in cytotoxic and cholestatic potential of the endothelial receptor antagonists using HepaRG cells","volume":"157","author":"Burbank","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2017.12.027","article-title":"Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis","volume":"68","author":"Turco","year":"2018","journal-title":"J. Hepatol."},{"issue":"S1","key":"10.1016\/j.pupt.2021.102071_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12072-017-9808-z","article-title":"New concepts on the clinical course and stratification of compensated and decompensated cirrhosis","volume":"12","author":"D'Amico","year":"2018","journal-title":"Hepatol. Int."},{"issue":"8","key":"10.1016\/j.pupt.2021.102071_bib31","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3748\/wjg.v25.i8.888","article-title":"Current and future pharmacological therapies for managing cirrhosis and its complications","volume":"25","author":"Kockerling","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"10\u201311","key":"10.1016\/j.pupt.2021.102071_bib32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/00365521.2018.1506046","article-title":"Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond","volume":"53","author":"Karagiannakis","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.pupt.2010.02.003","article-title":"Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats","volume":"23","author":"Kuang","year":"2010","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.pupt.2021.102071_bib34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.CIR.40.6.887","article-title":"Left ventricular diastolic pressure elevation consequent to pulmonary stenosis","volume":"40","author":"Herbert","year":"1969","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pupt.2021.102071_bib35","first-page":"161","article-title":"Right heart failure","volume":"38","author":"El Hajj","year":"2020","journal-title":"Cardiol. Clin."},{"issue":"1","key":"10.1016\/j.pupt.2021.102071_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4037\/aacnacc2020172","article-title":"Right ventricular failure","volume":"31","author":"Leeper","year":"2020","journal-title":"AACN Adv. Crit. Care"},{"issue":"7","key":"10.1016\/j.pupt.2021.102071_bib37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0002-9149(79)90439-9","article-title":"Right ventricular diastolic pressure in coronary artery disease","volume":"44","author":"Berman","year":"1979","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.pupt.2021.102071_bib38","first-page":"891","article-title":"\u201cForgotten No more,\u201d JACC hear","volume":"6","author":"Amsallem","year":"2018","journal-title":"Fail"},{"key":"10.1016\/j.pupt.2021.102071_bib39","doi-asserted-by":"crossref","unstructured":"G. P. Machado et al., \u201cDifferent prognostic value of white blood cell subtypes in patients with acute cerebral infarction.,\u201d Atherosclerosis, vol. 28, no. 2, pp. 221\u2013227, Oct. 2018, doi: 10.1177\/1076029613492011.","DOI":"10.1177\/1076029613492011"},{"key":"10.1016\/j.pupt.2021.102071_bib40","article-title":"Reverse cardiac remodeling: a marker of better prognosis in heart failure","author":"de","year":"2015","journal-title":"Arq. Bras. Cardiol."},{"issue":"3","key":"10.1016\/j.pupt.2021.102071_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.pupt.2021.102071_bib42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2169\/internalmedicine.42.465","article-title":"Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies","volume":"42","author":"Takano","year":"2003","journal-title":"Intern. Med."},{"issue":"5","key":"10.1016\/j.pupt.2021.102071_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1536\/ihj.17-576","article-title":"Right ventricular stroke work index","volume":"59","author":"Ibe","year":"2018","journal-title":"Int. Heart J."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:31:05Z","timestamp":1761082265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553921000833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"alternative-id":["S1094553921000833"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102071","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102071"}}